• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异珀罗替丁A及其鏻盐衍生物的制备与生物活性

Preparation and biological activity of isoperrottetin A and its phosphonium salts derivatives.

作者信息

Markuliak Mário, Kos Dominika, Vojáčková Veronika, Horváth Branislav, Švajdlenka Emil, Leskovská Janka, Pisárčik Martin, Kryštof Vladimír, Čížek Alois, Jampílek Josef, Lukáč Miloš

机构信息

Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University Bratislava, Kalinčiakova 8, 832 32 Bratislava, Slovakia.

Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palackeho 1946/1, 612 00 Brno, Czech Republic.

出版信息

Eur J Pharm Sci. 2025 Jun 11;212:107167. doi: 10.1016/j.ejps.2025.107167.

DOI:10.1016/j.ejps.2025.107167
PMID:40513683
Abstract

Bacterial resistance to antibiotics in use represents a critical threat to public health. The treatment of nosocomial, often life-threatening infections is often challenging and requires the search for new antibacterial compounds. In this study a series of phosphonium salts derived from bis(bibenzyl) isoperrottetin A were studied. Bis(bibenzyls) are compounds unique for liverworts. Phosphonium salts were prepared by an eight-step synthesis. The key steps in its preparation were the Ullmann reaction and the Wittig reaction. Ten phosphonium salts were prepared. Isoperrottetin A and its phosphonium salts were tested for antibacterial activity. Some of the compounds exhibit significant biological activity. Most of the prepared derivatives are more potent than the original isoperrottetin A. Compounds were evaluated for the antibacterial activity against selected Gram-positive bacteria such as Staphylococcus aureus, methicillin sensitive and resistant, Enterococcus faecalis and vancomycin sensitive and resistant and Gram-negative bacteria such as Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. Mycobacterium smegmatis and Mycobacterium marinum belonging to the genus Mycobacterium were also tested. Besides antibacterial activity, the compounds inhibit cell breathing and show cytotoxic activity against melanoma cells, retinal and epithelial cells. The results of antibacterial tests showed that the most effective compound is 5,5',5'',5'''-[1,7(1),4,5(1,3)-tetrabenzenaoctaphane-1,4,5,8-tetrayltetrakis(oxy)]tetrakis(5-oxo-P,P,P-triphenylpentane-1-phosphonium) tetrabromide (4P). The values of minimum bactericidal concentration (MBC) against S. aureus methicillin sensitive and resistant and E. faecalis vancomycin sensitive and resistant were < 1 µM. At the same time, the compound does not involve damaging the cell wall, as is known for cationic amphiphilic compounds, and showed favorable safety profiles at MBC values. These findings highlight the potential of compounds found in liverworts as active agents against sensitive and resistant bacterial strains. Chemical modification of bis(bibenzyls) with a phosphonium cation is promising in preparation of potent microbicidal compounds.

摘要

细菌对现有抗生素产生耐药性对公众健康构成了严重威胁。医院内感染往往危及生命,其治疗通常具有挑战性,需要寻找新的抗菌化合物。在本研究中,对一系列源自双(联苄基)异珀洛苔色素A的鏻盐进行了研究。双(联苄基)是苔类植物特有的化合物。鏻盐通过八步合成法制备。其制备的关键步骤是乌尔曼反应和维蒂希反应。制备了十种鏻盐。对异珀洛苔色素A及其鏻盐进行了抗菌活性测试。一些化合物表现出显著的生物活性。大多数制备的衍生物比原始的异珀洛苔色素A更有效。对这些化合物针对选定的革兰氏阳性菌如金黄色葡萄球菌(包括甲氧西林敏感和耐药菌株)、粪肠球菌(包括万古霉素敏感和耐药菌株)以及革兰氏阴性菌如大肠杆菌、铜绿假单胞菌和肺炎克雷伯菌的抗菌活性进行了评估。还测试了属于分枝杆菌属的耻垢分枝杆菌和海分枝杆菌。除抗菌活性外,这些化合物还抑制细胞呼吸,并对黑色素瘤细胞、视网膜细胞和上皮细胞表现出细胞毒性活性。抗菌测试结果表明,最有效的化合物是5,5',5'',5'''-[1,7(1),4,5(1,3)-四苯并辛八烷-1,4,5,8-四氧代]四(5-氧代-P,P,P-三苯基戊烷-1-鏻)四溴化物(4P)。其对甲氧西林敏感和耐药的金黄色葡萄球菌以及万古霉素敏感和耐药的粪肠球菌的最低杀菌浓度(MBC)值<1μM。同时,该化合物不像阳离子两亲性化合物那样会破坏细胞壁,并且在MBC值时显示出良好的安全性。这些发现突出了苔类植物中发现的化合物作为针对敏感和耐药细菌菌株的活性剂的潜力。用鏻阳离子对双(联苄基)进行化学修饰在制备强效杀菌化合物方面很有前景。

相似文献

1
Preparation and biological activity of isoperrottetin A and its phosphonium salts derivatives.异珀罗替丁A及其鏻盐衍生物的制备与生物活性
Eur J Pharm Sci. 2025 Jun 11;212:107167. doi: 10.1016/j.ejps.2025.107167.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Microbial isolates and resistance profiles in cerebrospinal fluid cultures: a five-year experience at a tertiary center.脑脊液培养中的微生物分离株与耐药谱:一家三级医疗中心的五年经验
Future Microbiol. 2025 Jul;20(10):669-680. doi: 10.1080/17460913.2025.2520666. Epub 2025 Jun 18.
4
Alcohol Sanitizer酒精消毒剂
5
High-throughput clinical antimicrobial susceptibility testing and drug-resistant subpopulation detection in Gram-negative bacteria.革兰氏阴性菌的高通量临床抗菌药敏试验及耐药亚群检测
Microbiol Spectr. 2025 Jul;13(7):e0001125. doi: 10.1128/spectrum.00011-25. Epub 2025 Jun 5.
6
Improved N-phenylpyrrolamide inhibitors of DNA gyrase as antibacterial agents for high-priority bacterial strains.作为高优先级细菌株的抗菌剂,改进的 N- 苯基吡咯烷酰胺类 DNA 拓扑异构酶抑制剂。
Eur J Med Chem. 2024 Nov 15;278:116823. doi: 10.1016/j.ejmech.2024.116823. Epub 2024 Sep 1.
7
Phosphonium-Substituted Conjugated Polyelectrolytes Display Efficient Visible-Light-Induced Antibacterial Activity.鏻取代的共轭聚电解质表现出高效的可见光诱导抗菌活性。
ACS Appl Mater Interfaces. 2024 Apr 24;16(16):20023-20033. doi: 10.1021/acsami.3c16335. Epub 2024 Jan 24.
8
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD003543. doi: 10.1002/14651858.CD003543.pub3.
9
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance.《2024年世界卫生组织细菌重点病原体清单》:一项用于指导针对抗菌药物耐药性的研究、开发及公共卫生策略的优先级排序研究。
Lancet Infect Dis. 2025 Apr 11. doi: 10.1016/S1473-3099(25)00118-5.
10
Biological activities of optimized biosynthesized selenium nanoparticles using Proteus mirabilis PQ350419 alone or combined with chitosan and ampicillin against common multidrug-resistant bacteria.单独使用奇异变形杆菌PQ350419或与壳聚糖和氨苄青霉素联合使用优化生物合成的硒纳米颗粒对常见多重耐药菌的生物活性。
Microb Cell Fact. 2025 Jul 5;24(1):159. doi: 10.1186/s12934-025-02783-0.